NHS must keep medicine rebate down or lose investment
NHS must keep medicine rebate down or lose investment is drawing significant interest across the industry.
The NHS must keep its medicines clawback tax low or else risk disrupting the rollout of weight-loss drugs, Novo Nordisk’s UK chief has said.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Lewis University moves classes online after learning about ICE lease
- Iranians in the Twin Cities watch, hope and wonder - what’s next?
- Minnesota Vikings receiver Rondale Moore found dead in his Indiana hometown
- Dem Va. Gov. Spanberger: Trump 'Did Not Hear the Truth'
Source: Original →